NVG-291: A Promising Clinical Trial for Spinal Cord Injury Recovery

In this video, Prof. Monica Perez presents the NVG-291 clinical trial and explains why researchers are watching this new approach to spinal cord injury recovery with great interest. NVG-291 is an experimental drug designed to support nervous system repair after spinal cord injury by targeting molecules that normally block regeneration. The hope is that, when combined with rehabilitation, it could help improve function and independence. Prof. Perez explains the scientific rationale behind NVG-291, how the clinical trial is being conducted, and what researchers are looking for in terms of safety and effectiveness. Although many questions still need to be answered, this study marks an important step forward in spinal cord injury research and a potentially promising direction for future recovery strategies. #NVG291 #SpinalCordInjury #ClinicalTrial #SCIRecovery #Neurorehabilitation #Findacure #scienceexplained #spinalcordinjuryrecovery